Propofol in Chemotherapy-Associated Nausea and Vomiting

Abstract

Get full access to this article

View all access options for this article.

References

Bleiberg

. Antiemetic agents. Curr Opin Oncol 1992; 4: 597–604.

Marty

Pouillart

Scholl

Droz

Azab

Brion

. Comparison of the 5-hydroxytryptamine₃ (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. N Engl J Med 1990; 322: 816–21.

Finley

. Nausea and vomiting. In: Koda-Kimble

Young

, eds. Applied therapeutics: the clinical use of drugs. Vancouver, WA: Applied Therapeutics, 1992: 3.

Grunberg

Hesketh

. Control of chemotherapy-induced emesis. N Engl J Med 1993; 329: 1790–6.

Triozzi

Laszlo

. Optimum management of nausea and vomiting in cancer chemotherapy. Drugs 1987; 34: 136–49.

Graves

. Emesis as a complication of cancer chemotherapy: pathophysiology, importance, and treatment. Pharmacotherapy 1992; 12: 337–45.

Cubeddu

. Mechanisms by which cancer chemotherapeutic drugs induce emesis. Semin Oncol 1992; 19 (6 suppl 15): 2–13.

Tortorice

O'Connell

. Management of chemotherapy-induced nausea and vomiting. Pharmacotherapy 1990; 10: 129–45.

Tyers

Freeman

. Mechanism of the anti-emetic activity of 5-HT₃ receptor antagonists. Oncology 1992; 49: 263–8.

10.

Cubeddu

Hoffmann

Fuenmayor

Finn

. Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. N Engl J Med 1990; 322: 810–6.

11.

Wilder-Smith

OHG

Borgeat

Chappuis

Fathi

Forni

. Urinary serotonin metabolite excretion during cisplatin chemotherapy. Cancer 1993; 72: 2239–41.

12.

Borgeat

Wilder-Smith

OHG

Suter

. The nonhypnotic therapeutic applications of propofol. Anesthesiology 1994; 80: 642–56.

13.

Product information. Diprivan (propofol). Wilmington, DE: Zeneca Pharmaceuticals, 1994.

14.

Sebel

Lowdon

. Propofol: a new intravenous anesthetic. Anesthesiology 1989; 71: 260–77.

15.

Borgeat

Wilder-Smith

OHG

Saiah

Rifat

. Subhypnotic doses of propofol possess direct antiemetic properties. Anesth Analg 1992; 74: 539–41.

16.

Ostman

Faure

Glosten

Kemen

Robert

Bedwell

. Is the antiemetic effect of the emulsion formulation of propofol due to the lipid emulsion? Anesth Analg 1990; 71: 53640.

17.

Borgeat

Wilder-Smith

OHG

Wilder-Smith

Forni

Suter

. Propofol improves patient comfort during cisplatin chemotherapy. Oncology 1993; 50: 456–9.

18.

Borgeat

Wilder-Smith

OHG

Wilder-Smith

Forni

Suter

. Adjuvant propofol for refractory cisplatin-associated nausea and vomiting. Lancet 1992; 340: 679–80.

19.

Borgeat

Wilder-Smith

Forni

Suter

. Adjuvant propofol enables better control of nausea and emesis secondary to chemotherapy for breast cancer. Can J Anaesth 1994; 41: 1117–9.

20.

Scher

Amar

McDowall

Barst

. Use of propofol for the prevention of chemotherapy-induced nausea and emesis in oncology patients. Can J Anaesth 1992; 39: 170–2.

21.

Hug

McLeskey

Nahrwold

Roizen

Stanley

Thisted

. Hemodynamic effects of propofol: data from over 25,000 patients. Anesth Analg 1993; 77 (suppl 4): S21–9.

22.

DiFlorio

. Is propofol a dopamine antagonist? Anesth Analg 1993; 77: 197–201.